Sec. 10. If:
(1) the federal government indicates that the federal government will withdraw all federal funds from a health care facility for allowing chymopapain to be used within the facility; and
(2) providing or allowing use of chymopapain within the facility would jeopardize the receipt of:
(A) federal funds for reimbursement for Medicare or Medicaid for all persons within the facility; or
(B) construction funds provided by the federal government under the Hill-Burton Hospital Construction Program (42 U.S.C. 291 et seq.) or under Title XVI of the Public Health Services Act (42 U.S.C. 300q-300t);
the hospital or other health care facility may prohibit the use of chymopapain within the hospital or facility.
[Pre-1993 Recodification Citation: 16-8-10-7(b).]
As added by P.L.2-1993, SEC.25.
Structure Indiana Code
Article 42. Regulation of Food, Drugs, and Cosmetics
Chapter 24. Drugs: Use of Chymopapain
16-42-24-2. Administration Restricted
16-42-24-3. Hospital's Restricting or Forbidding Use Prohibited; Conditions
16-42-24-4. Disciplinary Action Against Attending Physician Prohibited if Use Requested by Patient
16-42-24-5. Use Permitted in Place of Other Therapies if Requested by Patient
16-42-24-6. Construction of Chapter
16-42-24-8. Regulation of Manufacture, Distribution, Sale, or Use
16-42-24-9. Manufacture, Sale, Distribution, or Prescription Not Required
16-42-24-10. Use Prohibition by Health Care Facility Facing Loss of Federal Funding